SanjayRajagopalanMD

Cardiology • Cleveland, OH

Cardiothoracic Imaging, Preventive Cardiology

Professor of Medicine and Radiology University Hospitals, Case Western Reserve School of Medicine, Cleveland, OH

Join to view full profile

Dr. Rajagopalan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Rajagopalan's full profile

Already have an account?

Office
11100 Euclid Ave
Cleveland, OH 44106
Phone+1 216-844-1000

Education & Training

Emory University School of MedicineFellowship, Cardiovascular Disease, 1994 - 1998
University at BuffaloResidency, Internal Medicine, 1990 - 1994
Stanley Medical College SMCClass of 1990

Certifications & Licensure

OH State Medical License 2006 - 2026
MD State Medical License 2013 - 2017
MI State Medical License 1993 - 2008
NY State Medical License 2004 - 2007
GA State Medical License 1994 - 1999
American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Fellow (FACC) American College of Cardiology

Clinical Trials

Aliskerin Effect on Plaque Progression in Established Atherosclerosis Using High Resolution 3D MRI: A Double Blind Placebo Controlled Trial Start of enrollment: 2010 Mar 01
Aliskiren Effect on Aortic Plaque Progression Start of enrollment: 2009 Oct 01
Terminated
Phase 2, Phase 3
Environmental Triggers Of Cardiometabolic Disease Start of enrollment: 2011 Feb 01
Completed
Mineralocorticoid Receptor Antagonism Clinical Evaluation in Atherosclerosis Trial Start of enrollment: 2016 Jan 01
Completed
Phase 4
Mineralocorticoid Receptor Antagonism Clinical Evaluation in Atherosclerosis Add-On Start of enrollment: 2018 Jul 17
Terminated
Phase 4
Project 3: ACHIEVE- CHD Start of enrollment: 2022 Aug 15
Recruiting
Not Applicable
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

Environmental Hypertensionology and the Mosaic Theory of Hypertension.
Sanjay Rajagopalan, Robert D Brook, Thomas Münzel
Hypertension. 2025-04-01
3 citations
Environmental sustainability in cardiovascular practice: current challenges and future directions.
Sanjay Rajagopalan, Scott McAlister, Jason Jay, Richard D Pham, Robert D Brook
Nature Reviews. Cardiology. 2025-04-01
The community health worker model for cardiovascular kidney metabolic syndrome: A new paradigm for high value care.
Sanjay Rajagopalan, Jeshurun Adarquah-Yiadom, Fonda Mcclain, John Pastor Ansah, Heidi Osborne
American Journal of Preventive Cardiology. 2025-03-01

Journal Articles

Air Pollution and Cardiovascular Disease
Sanjay Rajagopalan, MD, ScienceDirect
Central IKK2 Inhibition Ameliorates Air Pollution-Mediated Hepatic Glucose and Lipid Metabolism Dysfunction in Mice with Type II Diabetes
Sanjay Rajagopalan, MD, Toxicological Sciences

Authored Content

Reply Pollution and Organ TransplantationJune 2020

Press Mentions

Extreme Heat Seems to Spark More Atrial Arrhythmias in IED PatientsNovember 19th, 2024
Extreme Heat May Increase Risk of Irregular Heartbeat in People with Implanted DefibrillatorsNovember 11th, 2024
Triple-Digit Heat Waves Could Pose Danger to Implanted DefibrillatorsNovember 11th, 2024
Join now to see all

Grant Support

(CIRCADIAN) Circadian Disruption as Mediator of Cardiometabolic Risk in Air PollutionCASE WESTERN RESERVE UNIVERSITY2021–2029
(CIRCADIAN) Circadian Disruption as Mediator of Cardiometabolic Risk in Air PollutionCASE WESTERN RESERVE UNIVERSITY2021–2029
(CIRCADIAN) Circadian Disruption as Mediator of Cardiometabolic Risk in Air PollutionCASE WESTERN RESERVE UNIVERSITY2021–2029
(CIRCADIAN) Circadian Disruption as Mediator of Cardiometabolic Risk in Air PollutionCASE WESTERN RESERVE UNIVERSITY2021–2029
(CIRCADIAN) Circadian Disruption as Mediator of Cardiometabolic Risk in Air PollutionCASE WESTERN RESERVE UNIVERSITY2021–2029
(CIRCADIAN) Circadian Disruption as Mediator of Cardiometabolic Risk in Air PollutionCASE WESTERN RESERVE UNIVERSITY2021–2029
Pericoronary fat: MACE risk from non-contrast CT and the role of iodine perfusion in contrast CTCASE WESTERN RESERVE UNIVERSITY2023–2027
Cardiovascular risk from comprehensive evaluation of the CT calcium score examCASE WESTERN RESERVE UNIVERSITY2023–2027
Targets and targeting of immunometabolism in chronic PM2.5 exposureCASE WESTERN RESERVE UNIVERSITY2022–2026
Targets and targeting of immunometabolism in chronic PM2.5 exposureCASE WESTERN RESERVE UNIVERSITY2022–2026
Targets and targeting of immunometabolism in chronic PM2.5 exposureCASE WESTERN RESERVE UNIVERSITY2022–2026
Targets and targeting of immunometabolism in chronic PM2.5 exposureCASE WESTERN RESERVE UNIVERSITY2022–2026
Targets and targeting of immunometabolism in chronic PM2.5 exposureCASE WESTERN RESERVE UNIVERSITY2022–2026
Targets and targeting of immunometabolism in chronic PM2.5 exposureCASE WESTERN RESERVE UNIVERSITY2022–2026